Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Kevin T Hogan John D. Roberts Cody J Peer William Douglas Figg, Sr. |
| Publication date | September 23, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |